Robert Easton

Bio

Robert is a Senior Adviser and supports our Growth investment strategy. Dr Robert Easton is a Partner and Senior Adviser at The Carlyle Group, the global alternative asset management company. He is a veteran of the firm and has performed multiple roles as an investment professional, including running the buyout team in the UK, serving as co-head of Carlyle Europe Technology Partners, a family of funds focussed on growth capital investments across the European technology sector and leading Carlyle’s Ireland focussed fund. Across his 15 years at the firm, he has served on multiple portfolio company boards and gained sector expertise in media, software, advanced materials, renewables, chemicals and aerospace and defence. Prior to joining Carlyle in 2000, Dr Easton was Vice President of Corporate Development at Invensys plc. Dr Easton joined BTR in 1996 and was a key figure in the transformation of BTR from a diversified conglomerate to a focused engineering group and in the formation of Invensys from the merger of BTR and Siebe in 1999. During this period, he executed a total of 35 acquisitions and disposals with an aggregate value of €7 billion. Dr Easton is currently an independent non-executive Director of Imperial Innovations Group, a past Chairman of the British Venture Capital Association and a founding Director of the Walker Guidelines Monitoring Group for private equity disclosure. In addition, he is a Trustee of the British Heart Foundation, a member of the Imperial College Business School Advisory Board and a Director and investor in numerous start-up companies. Dr Easton has a first class honours degree in chemistry from Imperial College London and a Doctorate in organic synthesis from Oxford University.